CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 12/31/2014

Position Statistics

Total Positions 75
New Positions 11
Increased Positions 27
Decreased Positions 16
Positions with Activity 43
Sold Out Positions 6
Total Mkt Value (in $ millions) 718

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 13.58%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 60.03%
Services
Technology
Transportation
Utilities

75 Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
ROCKWELL MED INC COM 4,000 New 400,000
VERSARTIS INC COM 3,962 New 200,000
GLYCOMIMETICS INC COM 3,930 New 472,300
AGENUS INC COM NEW 3,920 735 23.08 800,000
CERULEAN PHARMA INC COM 3,704 New 450,000
FORWARD PHARMA A/S SPONSORED ADR 3,492 3,492 New 150,000
DERMIRA INC COM 3,346 3,346 New 200,000
NANOSTRING TECHNOLOGIES INC COM 3,153 New 300,000
IMMUNE DESIGN CORP COM 3,086 -1,322 (30) 140,000
AQUINOX PHARMACEUTICALS INC COM 2,925 New 300,000
RECRO PHARMA INC COM 2,387 New 700,000
AVALANCHE BIOTECHNOLOGIES INC COM 2,352 New 65,000
KINDRED BIOSCIENCES INC COM 2,349 New 350,000
CURIS INC COM 1,848 New 600,000
AGILE THERAPEUTICS INC COM 1,626 New 150,000
CELLECTAR BIOSCIENCES INC COM NEW 1,500 New 530,000
BELLICUM PHARMACEUTICALS INC COM 1,393 1,393 New 60,000
APPLIED GENETIC TECHNOL CORP COM 1,230 New 60,600
AKEBIA THERAPEUTICS INC COM 1,093 -2,611 (70.5) 118,000
GALECTIN THERAPEUTICS INC COM NEW 1,061 -471 (30.73) 312,000